MAPT and Alzheimer disease: A lateral flow assay based on SERS nanotags (SERS-LFA) has been developed, allowing simultaneous quantification of multiple AD biomarkers, including Aβ42, Aβ40, tau protein, and neurofilament light chain, a marker of neuronal damage [82].